Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561182 · ClinicalTrials.gov registry record
Bone Health in Patients With Overgrowth
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 30
- Enrollment target
NCT02561182: Completed study, sponsored by Mayo Clinic.
NCT02561182 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02561182 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether or not patients with overgrowth syndromes have decreased bone density.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-05-23 |
What the finished NCT02561182 record still lists
NCT02561182 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02561182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02561182 about?
NCT02561182 is a clinical study titled "Bone Health in Patients With Overgrowth". The goal of this study is to determine whether or not patients with overgrowth syndromes have decreased bone density.
What is the current status of trial NCT02561182?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2015-09. Estimated completion is 2019-05-23.
Who is sponsoring clinical trial NCT02561182?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia